Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA May Change Advisory Committee Planning, Member Screening

Executive Summary

Departing Commissioner says that special government employee procedure especially is in need of reform.


Related Content

US FDA May Create Rare Disease Expert Pool For Advisory Committee Reviews
Advocates Press For US FDA Rare Disease Center Of Excellence
Advisory Committees: FDA Gets Out Of The Redaction Business
Advisory Committees: US FDA Gets Out Of The Redaction Business
Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’
Trump Meets With Two US FDA Commissioner Candidates; Third Still Lurking
US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure
US FDA Has Slim Advisory Committee Schedule – A Sign Of Things Not To Come?
FDA Conflict Of Interest Screening Could Get Streamlined As Patient Involvement Increases





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts